Difficulty: Medium
Average Score: 93%
Practice
A 5-year-old child, recently diagnosed with ileocecal Burkitt lymphoma; lab investigations reveal: serum uric acid 12 mg/dl, serum sodium, 145 meq/dl; serum potassium, 4.5 meq/dl; serum phosphate 4.4 meq/dl; serum calcium, 8.9 mg/dl; blood urea, 22 mg/dl; serum creatinine, 0.8 mg/dl. Of the following, the MOST effective treatment is
Correct answer
D
Rationale
The most effective treatment for a child with ileocecal Burkitt lymphoma presenting with hyperuricemia (serum uric acid 12 mg/dl) is option D, recombinant urate oxidase. This enzyme helps to break down uric acid into a more soluble form, lowering serum levels and preventing complications like tumor lysis syndrome.
Option A, excessive hydration, may help prevent renal damage from uric acid crystals but is not as effective in rapidly reducing elevated uric acid levels. Option B, sodium bicarbonate, is used to alkalinize urine and prevent uric acid crystallization in the renal tubules but does not directly lower serum levels. Option C, xanthine oxidase inhibitor, is used in chronic hyperuricemia like gout but is not as effective in acute tumor lysis syndrome.
In an educational context, understanding the pathophysiology of tumor lysis syndrome and the role of urate oxidase in lowering uric acid levels is crucial in managing pediatric oncology patients. It highlights the importance of prompt and effective intervention to prevent life-threatening complications.
Option A, excessive hydration, may help prevent renal damage from uric acid crystals but is not as effective in rapidly reducing elevated uric acid levels. Option B, sodium bicarbonate, is used to alkalinize urine and prevent uric acid crystallization in the renal tubules but does not directly lower serum levels. Option C, xanthine oxidase inhibitor, is used in chronic hyperuricemia like gout but is not as effective in acute tumor lysis syndrome.
In an educational context, understanding the pathophysiology of tumor lysis syndrome and the role of urate oxidase in lowering uric acid levels is crucial in managing pediatric oncology patients. It highlights the importance of prompt and effective intervention to prevent life-threatening complications.